Cytek BioSciences 

$3.77
28
-$0.21-5.28% Thursday 20:00

統計

當日最高
4.08
當日最低
3.7
52週高點
6.18
52週低點
2.9
成交量
15,687,850
平均成交量
-
市值
482.05M
本益比
-
股息殖利率
-
股息
-

即將到來

財報

12Aug預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
下一步
-0.15
-0.06
0.03
0.12
預期EPS
-0.085
實際EPS
不適用

財務

-3%利潤率
未盈利
2020
2021
2022
2023
2024
400.91M營收
-12.04M淨利

分析師評級

5.08平均目標價
最高預估為 5.50。
來自過去6個月內的 3 則評分。這不是投資建議。
買入
67%
持有
33%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 CTKB 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.
Show more...
執行長
Dr. Wenbin Jiang Ph.D.
員工
663
國家
美國
ISIN
US23285D1090

上市

0 Comments

分享你的想法

FAQ

Cytek BioSciences 今天的股價是多少?
CTKB 目前價格為 $3.77 USD,過去 24 小時下跌了 -5.28%。在圖表上更密切關注 Cytek BioSciences 股票的表現。
Cytek BioSciences 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Cytek BioSciences 的股票以代號 CTKB 進行交易。
Cytek BioSciences 的股價在上漲嗎?
CTKB 股票較上週下跌 -4.8%,本月下跌 -4.8%,但在過去一年中,Cytek BioSciences 上漲了 +27.8%。
Cytek BioSciences 的市值是多少?
今天 Cytek BioSciences 的市值為 482.05M
Cytek BioSciences 下一次財報日期是什麼時候?
Cytek BioSciences 將於 August 12, 2026 公布下一次財報。
Cytek BioSciences 上一季度的財報如何?
CTKB 上一季度的財報為每股 -0.15 USD,預估為 -0.09 USD,帶來 -62.16% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Cytek BioSciences 去年的營收是多少?
Cytek BioSciences 去年的營收為 400.91MUSD。
Cytek BioSciences 去年的淨利是多少?
CTKB 去年的淨收益為 -12.04MUSD。
Cytek BioSciences 有多少名員工?
截至 June 21, 2026,公司共有 663 名員工。
Cytek BioSciences 位於哪個產業?
Cytek BioSciences從事於Health & Wellness產業。
Cytek BioSciences 何時完成拆股?
Cytek BioSciences 最近沒有進行任何拆股。
Cytek BioSciences 的總部在哪裡?
Cytek BioSciences 的總部位於 美國 的 Fremont。